Major Work Ahead To Make "Mini" Sentinel System Work On A Larger Scale
This article was originally published in The Gray Sheet
Executive Summary
FDA's new "mini-Sentinel" project fulfills a statutory requirement to establish a national post-market drug safety surveillance system linking data on 25 million patients by July 1, but will not track device data for at least the first year, the agency says
You may also be interested in...
Regulatory News In Brief
Sentinel workshop
Regulatory News In Brief
Sentinel workshop
Regulatory News In Brief
CDRH pursuing workplace fixes